Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 4
2005 9
2006 5
2007 1
2008 5
2009 2
2010 3
2011 4
2012 5
2013 3
2014 4
2015 7
2016 4
2017 4
2018 7
2019 11
2020 8
2021 7
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Results by year

Filters applied: . Clear all
Page 1
Targeted molecular radiotherapy.
Kersemans V. Kersemans V. Curr Drug Discov Technol. 2010 Dec;7(4):232. doi: 10.2174/157016310793360666. Curr Drug Discov Technol. 2010. PMID: 21034412 No abstract available.
PET Imaging of PARP Expression Using 18F-Olaparib.
Wilson TC, Xavier MA, Knight J, Verhoog S, Torres JB, Mosley M, Hopkins SL, Wallington S, Allen PD, Kersemans V, Hueting R, Smart S, Gouverneur V, Cornelissen B. Wilson TC, et al. Among authors: kersemans v. J Nucl Med. 2019 Apr;60(4):504-510. doi: 10.2967/jnumed.118.213223. Epub 2018 Nov 2. J Nucl Med. 2019. PMID: 30389822 Free PMC article.
Imaging PARP with [18F]rucaparib in pancreatic cancer models.
Chan CY, Chen Z, Destro G, Veal M, Lau D, O'Neill E, Dias G, Mosley M, Kersemans V, Guibbal F, Gouverneur V, Cornelissen B. Chan CY, et al. Among authors: kersemans v. Eur J Nucl Med Mol Imaging. 2022 Sep;49(11):3668-3678. doi: 10.1007/s00259-022-05835-4. Epub 2022 May 26. Eur J Nucl Med Mol Imaging. 2022. PMID: 35614267 Free PMC article.
Tumor Imaging Using Radiolabeled Matrix Metalloproteinase-Activated Anthrax Proteins.
Elvina Xavier MA, Liu S, Bugge TH, Torres JB, Mosley M, Hopkins SL, Allen PD, Berridge G, Vendrell I, Fischer R, Kersemans V, Smart S, Leppla SH, Cornelissen B. Elvina Xavier MA, et al. Among authors: kersemans v. J Nucl Med. 2019 Oct;60(10):1474-1482. doi: 10.2967/jnumed.119.226423. Epub 2019 Apr 6. J Nucl Med. 2019. PMID: 30954944 Free PMC article.
Endothelial cell death after ionizing radiation does not impair vascular structure in mouse tumor models.
Kaeppler JR, Chen J, Buono M, Vermeer J, Kannan P, Cheng WC, Voukantsis D, Thompson JM, Hill MA, Allen D, Gomes A, Kersemans V, Kinchesh P, Smart S, Buffa F, Nerlov C, Muschel RJ, Markelc B. Kaeppler JR, et al. Among authors: kersemans v. EMBO Rep. 2022 Sep 5;23(9):e53221. doi: 10.15252/embr.202153221. Epub 2022 Jul 18. EMBO Rep. 2022. PMID: 35848459 Free PMC article.
Imaging DNA Damage Repair In Vivo After 177Lu-DOTATATE Therapy.
O'Neill E, Kersemans V, Allen PD, Terry SYA, Torres JB, Mosley M, Smart S, Lee BQ, Falzone N, Vallis KA, Konijnenberg MW, de Jong M, Nonnekens J, Cornelissen B. O'Neill E, et al. Among authors: kersemans v. J Nucl Med. 2020 May;61(5):743-750. doi: 10.2967/jnumed.119.232934. Epub 2019 Nov 22. J Nucl Med. 2020. PMID: 31757844 Free PMC article.
Enhanced antitumor immunity through sequential targeting of PI3Kδ and LAG3.
Lauder SN, Smart K, Kersemans V, Allen D, Scott J, Pires A, Milutinovic S, Somerville M, Smart S, Kinchesh P, Lopez-Guadamillas E, Hughes E, Jones E, Scurr M, Godkin A, Friedman LS, Vanhaesebroeck B, Gallimore A. Lauder SN, et al. Among authors: kersemans v. J Immunother Cancer. 2020 Oct;8(2):e000693. doi: 10.1136/jitc-2020-000693. J Immunother Cancer. 2020. PMID: 33093155 Free PMC article.
87 results